Page 391«..1020..390391392393..400410..»

An Aging Population is Increasing the Need for Novel Treatments – PRNewswire

Posted: Published on February 4th, 2021

NEW YORK, Feb. 3, 2021 /PRNewswire/ --With the onset of a world health crisis, our seniors are at a greater risk than they were a decade ago Continue reading

Posted in Parkinson's Treatment | Comments Off on An Aging Population is Increasing the Need for Novel Treatments – PRNewswire

Global Alzheimer’s Disease Treatment Market Report 2020: Market is Expected to Recover in 2023 – Forecast to 2030 – ResearchAndMarkets.com – Yahoo…

Posted: Published on February 4th, 2021

The "Alzheimer's Disease Treatment Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering. Continue reading

Posted in Parkinson's Treatment | Comments Off on Global Alzheimer’s Disease Treatment Market Report 2020: Market is Expected to Recover in 2023 – Forecast to 2030 – ResearchAndMarkets.com – Yahoo…

FDA Action Alert: Adamas, Mallinckrodt and Merck – BioSpace

Posted: Published on February 4th, 2021

February is kicking off with a number of PDUFA dates for the U.S. Continue reading

Posted in Parkinson's Treatment | Comments Off on FDA Action Alert: Adamas, Mallinckrodt and Merck – BioSpace

February is American Heart Month | Center Light and Champion – The Light and Champion

Posted: Published on February 4th, 2021

American Heart Month February is American Heart Month. Cardiovascular disease is the leading cause of death in The United States and approximately 1.5 million heart attacks and strokes occur every year. Morethan 800,000 people in the U.S Continue reading

Posted in Parkinson's Treatment | Comments Off on February is American Heart Month | Center Light and Champion – The Light and Champion

Five things for pharma marketers to know: Thursday, February 4, 2021 – Roundup – MM&M – Medical Marketing and Media – Medical Marketing and Media

Posted: Published on February 4th, 2021

AstraZenecas COVID-19 vaccine reduced transmission of the virus and appeared to offer protection with one dose, a new study found. The results may support the U.K.s plan to delay second shots. (AP) Jazz Pharmaceuticals announced it will buy GW Pharma for $7.2 billion Continue reading

Posted in Parkinson's Treatment | Comments Off on Five things for pharma marketers to know: Thursday, February 4, 2021 – Roundup – MM&M – Medical Marketing and Media – Medical Marketing and Media

The Recovery Room: News beyond the pandemic January 29 – Medical News Today

Posted: Published on February 4th, 2021

The coronavirus pandemic dominated the headlines and our daily lives for most of the past year. Medical News Today have covered this fast-moving, complex story with live updates on the latest news, interviews with experts, and an ongoing investigation into the deep racial disparities that COVID-19 has helped unmask. However, this hasnt stopped us from publishing hundreds of fascinating stories on a myriad of other topics Continue reading

Posted in Parkinson's Treatment | Comments Off on The Recovery Room: News beyond the pandemic January 29 – Medical News Today

Seelos Therapeutics to Participate in Canaccord Genuity’s New Paradigms and Treatment Approaches in Mental Health Conference February 3-4 – PRNewswire

Posted: Published on February 4th, 2021

NEW YORK, Feb. 1, 2021 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will participate in Canaccord Genuity's New Paradigms and Treatment Approaches in Mental Health virtual conference, Wednesday, February 3rd and Thursday, February 4th, 2021. Continue reading

Posted in Parkinson's Treatment | Comments Off on Seelos Therapeutics to Participate in Canaccord Genuity’s New Paradigms and Treatment Approaches in Mental Health Conference February 3-4 – PRNewswire

Sio Gene Therapies Announces First Patient Dosed in Clinical Trial of AXO-AAV-GM2 in Patients with Tay-Sachs and Sandhoff Disease (GM2 Gangliosidosis)…

Posted: Published on February 4th, 2021

- First potentially disease-modifying gene therapy for GM2 gangliosidosis to enter clinical studies - Expect to continue patient identification, screening, and enrollment in Stage 1 of the study throughout 2021 NEW YORK and RESEARCH TRIANGLE PARK, N.C., Feb. Continue reading

Posted in Parkinson's Treatment | Comments Off on Sio Gene Therapies Announces First Patient Dosed in Clinical Trial of AXO-AAV-GM2 in Patients with Tay-Sachs and Sandhoff Disease (GM2 Gangliosidosis)…

Coya Therapeutics Completes Merger with Nicoya Health Inc. and Announces $10 Million Series A Financing to Advance Pipeline of Regulatory T cell…

Posted: Published on February 4th, 2021

-Seminal discoveries in regulatory T-cell (Treg) biology; Novel cryopreservation and manufacturing innovations based on the research of Stanley H. Appel, M.D., internationally renowned researcher and neurologist- HOUSTON, Feb Continue reading

Posted in Parkinson's Treatment | Comments Off on Coya Therapeutics Completes Merger with Nicoya Health Inc. and Announces $10 Million Series A Financing to Advance Pipeline of Regulatory T cell…

Lablogatory A blog for medical laboratory professionals

Posted: Published on February 4th, 2021

COVID-19 testing can be a bit confusing. Recently, ASCP released two recommendations for COVID-19 testing to help clinicians and laboratories sort through the noise and order the right test at the right time Continue reading

Posted in Medical Technology | Comments Off on Lablogatory A blog for medical laboratory professionals

Page 391«..1020..390391392393..400410..»